Schmiedeberg in Strassburg 1872–1918: The making of modern pharmacology

doi:10.1016/0024-3205(78)90099-1

Life Sciences

Volume 22, Issues 13–15, April 1978, Pages 1361-1371

https://doi.org/10.1016/0024-3205(78)90099-1 Get rights and content

Abstract

One century ago pharmacology was an antiquated, denigrated and waning discipline content with transmitting impressionistic and largely erroneous dictums. In one generation one man in one city redefined its tasks, demonstrated its experimental methods and trained its work force. Virchow, Pasteur and Koch profoundly influenced their fields, but Schmiedeberg brought scientific pharmacology into being. Their names have become household words, his is rarely found even in medical dictionaries. Fortunately, he cared not about fame but about knowledge.

References (14)

G. Kuschinsky
J. Hist. Med.
(1968)
E.R. Habermann
Annu. Rev. Pharmacol.
(1974)
O. Schmiedeberg
Arch. Exp. Pathol. Pharmakol.
(1912)
J.J. Abel
J. Pharmacol. Exp. Ther.
(1926)
H.H. Meyer
Naturwissenschaften
(1922)
T. Billroth
Ueber das Lehren und Lernen der medizinischen Wissenschaften an den Universitäten deutscher Nation
R. Buchheim
Arch. Exp. Pathol. Pharmakol.
(1878)

There are more references available in the full text version of this article.

Cited by (17)

Introduction to drug design and discovery
2022, Computer Aided Drug Design (CADD): From Ligand-Based Methods to Structure-Based Approaches
Population growth and environmental problems have led to the emergence or worsening of many diseases. In this scenario, the challenge of discovering new drugs capable of alleviating human suffering and providing a better quality of life is imposed. The concepts of drug discovery and drug design can occasionally be confused. Drug discovery involves several paths, ranging from chance to systematic search, using experimental and computational resources. The design of drugs, in turn, refers to the use of a systematic method, usually based on the structure of the biological target and on previous knowledge about the biochemistry of the disease, to find promising compounds.
Biomedical Research in the 21st Century: Multiple Challenges in Resolving Reproducibility Issues
2018, Research in the Biomedical Sciences: Transparent and Reproducible
The documented lack of reproducibility in biomedical research directly impacts the value and output of drug discovery disciplines like pharmacology that are integral for understanding disease pathophysiology, the discovery of drug targets, and the development of new drug candidates. This chapter discusses the reproducibility issue in the context of the challenges facing the biopharmaceutical industry in the 21st century. These include drug costs and productivity; the perceived impact of the biotechnology revolution and newer disruptive technology initiatives from Silicon Valley companies. These issues are placed in the context of the systemic flaws and perverse career incentives that characterize the current biomedical research culture, the unintended consequences from which appear to sufficient consequences to change behaviors that result in bad science. This emphasizes the need for the biomedical research community to proactively improve reproducibility via initiatives like the recent AAM Framework for Improving the Quality of Research.
An Historical Introduction to Biased Signaling
2014, Biased Signaling in Physiology, Pharmacology and Therapeutics
Organisms have evolved the ability to sense and respond to external chemical and physical cues through specific receptors. Within cells, receptors interact with internal and external partners in a cell-specific fashion in order to develop tissue specificity of function. The recognition of ligands and the ultimate activation of signal transduction pathways by receptors are dependent upon the conformational fluidity of the receptor. Nature has evolved several different types of receptors that we categorize based upon their structure and signaling activity; however, the general principles of activation of intracellular signals are similar. Ligands to nuclear receptors and G protein coupled receptors have been found to induce ligand-specific signal-transduction pathways, most recently termed biased signaling. Given the importance of receptor conformation in signal transduction activation, it is likely that biased signaling also occurs with cytokine receptor/receptor tyrosine kinases and ligand-gated ion channels. Indeed, recent observations have found that these receptor classes also exhibit ligand-dependent biased signaling properties. In this chapter, we will briefly discuss the evolution of pharmacology and the receptor theory up to elucidation of biased signaling, and provide a general overview of how biased signaling can impact physiology, pharmacology and the development of new therapeutics. Subsequent chapters will provide more in depth information on how biased signaling affects each receptor class, how biased signaling is impacted by the intracellular milieu, and how elucidation of this phenomenon can be harnessed to better understand physiology and design improved therapeutics.
Pharmacology in Germany
1998, Trends in Pharmacological Sciences
Reflections on the history of pharmacology
1982, Trends in Pharmacological Sciences
History of pharmacology:2 - The Institute of Pharmacology of the University of Strasbourg: genealogy and biographies
2023, Naunyn-Schmiedeberg's Archives of Pharmacology

View all citing articles on Scopus

View full text

Schmiedeberg in Strassburg 1872–1918: The making of modern pharmacology

Abstract

J. Hist. Med.

Annu. Rev. Pharmacol.

Arch. Exp. Pathol. Pharmakol.

J. Pharmacol. Exp. Ther.

Naturwissenschaften

Ueber das Lehren und Lernen der medizinischen Wissenschaften an den Universitäten deutscher Nation

Arch. Exp. Pathol. Pharmakol.